Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Disease Obstructive Pulmonary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT07620912
What this trial is testing

Sedation vs No Sedation in Mechanically Ventilated COPD Patients

Who this might be right for
Chronic Obstructive Pulmonary DiseaseRespiratory Failure
Al-Azhar University 100
Not applicableLooking for participantsNCT05008081
What this trial is testing

The CATALINA Study

Who this might be right for
Chronic Obstructive Pulmonary Disease Exacerbation
Wim Janssens 1,000
Post-approval studies (Phase 4)UnknownNCT05209607
What this trial is testing

Social Media-based Bundle Care of AECOPD Patients.

Who this might be right for
Acute Exacerbation of COPDPulmonary Disease, Chronic ObstructiveCOPD+5 more
Beijing Chao Yang Hospital 648
Not applicableUnknownNCT05681364
What this trial is testing

Prediction of Pulmonary Rehabilitation Outcomes in Patients With Chronic Respiratory Disease Based on Metabolomics: a Prospective Cohort Study

Who this might be right for
Chronic Obstructive Pulmonary DiseaseBronchiectasis
Peking University Third Hospital 300
Post-approval studies (Phase 4)Study completedNCT01124422
What this trial is testing

Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 255
Not applicableStudy completedNCT03086551
What this trial is testing

Modulating Interaction of Motor Learning Networks in Rehabilitation of Stroke

Who this might be right for
StrokeStroke, ChronicStroke, Middle Cerebral Artery With Infarction
University of Michigan 12
Not applicableStudy completedNCT00875719
What this trial is testing

Oxygen Portable Concentrator During Exercises in Patients With COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche 19
Not applicableStudy completedNCT07472530
What this trial is testing

Respiratory Exercises in Frail Elderly COPD Patients

Who this might be right for
FrailityCOPD (Chronic Obstructive Pulmonary Disease)Older Adults (65 Years and Older)
Çankırı Karatekin University 66
Large-scale testing (Phase 3)WithdrawnNCT00716053
What this trial is testing

Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema

Who this might be right for
Advanced Upper Lobe Predominant Emphysema
Aeris Therapeutics 225
Post-approval studies (Phase 4)Study completedNCT02596009
What this trial is testing

Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices

Who this might be right for
Pulmonary Disease, Chronic Obstructive (COPD)
Novartis Pharmaceuticals 97
Testing effectiveness (Phase 2)Study completedNCT02981602
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection

Who this might be right for
Hepatitis BChronic Hepatitis B Atypical
GlaxoSmithKline 31
Post-approval studies (Phase 4)Study completedNCT01796730
What this trial is testing

Effects and Safety of Different Dose of Bambuterol on Chinese COPD Patients

Who this might be right for
COPD
The First Affiliated Hospital of Guangzhou Medical University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07125664
What this trial is testing

Intravenous Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study)

Who this might be right for
Acute Exacerbation Chronic Obstructive Pulmonary Disease
Fondazione IRCCS Policlinico San Matteo di Pavia 36
Not applicableStudy completedNCT01564953
What this trial is testing

Magnesium is Associated With QoL in COPD: A Cross-sectional Study

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
University of Aarhus 143
Not applicableStudy completedNCT07660757
What this trial is testing

Epidemiological Cluster Evaluation in Patients Admitted to Internal Medicine, With at Least One of the Following Diagnoses: Heart Failure, COPD, Renal Failure. The FADOI IN-CluDiMI Study

Who this might be right for
Heart FailureChronic Obstructive Pulmonary Disease (COPD)Chronic Kidney Disease (CKD)
Fadoi Foundation, Italy 4,500
Post-approval studies (Phase 4)Active Not RecruitingNCT02386800
What this trial is testing

CINC424A2X01B Rollover Protocol

Who this might be right for
Primary MyelofibrosisPolycythemia VeraGraft Versus Host Disease+2 more
Novartis Pharmaceuticals 279
Not applicableStudy completedNCT07414134
What this trial is testing

Exacerbations and Real-World Outcomes Among Patients With Chronic Obstructive Pulmonary Disease Following Severe Exacerbation

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 3,598
Testing effectiveness (Phase 2)Study completedNCT02105012
What this trial is testing

Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma

Who this might be right for
Asthma
Pearl Therapeutics, Inc. 147
Testing effectiveness (Phase 2)Ended earlyNCT03345407
What this trial is testing

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 943
Large-scale testing (Phase 3)Looking for participantsNCT07177339
What this trial is testing

EValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 1,196
Next Page